Veterinary Medicines

Broncho- logoplex cseppek A.U.V.

Authorised
  • YERBA SANTA D3
  • AMMI VISNAGA D3
  • AMMONIUM CARBONICUM D6
  • Grindelia robusta D3
  • LOBELIA INFLATA D3
Download as PDF

Product identification

Medicine name:
Broncho- logoplex cseppek A.U.V.
Active substance:
  • YERBA SANTA D3
  • AMMI VISNAGA D3
  • AMMONIUM CARBONICUM D6
  • Grindelia robusta D3
  • LOBELIA INFLATA D3
Target species:
  • Cattle
  • Sheep
  • Goat
  • Horse
  • Pig
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • YERBA SANTA D3
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • AMMI VISNAGA D3
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • AMMONIUM CARBONICUM D6
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Grindelia robusta D3
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • LOBELIA INFLATA D3
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle
    • Sheep
    • Goat
    • Horse
    • Pig
    • Dog
    • Cat
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Homeopathic medicinal products (Article 19 of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Medicus Partner Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cefak KG
Responsible authority:
  • NEBIH
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."